Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Next Previous
X
Search
Trial Profile

A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Liprotamase (Primary) ; Pancrelipase
  • Indications Exocrine pancreatic insufficiency
  • Focus Registrational; Therapeutic Use
  • Acronyms RESULT
  • Sponsors Anthera Pharmaceuticals

    • Most Recent Events

    • 21 Apr 2018 Planned number of patients changed from 140 to 150.
    • 12 Mar 2018 According to an Anthera Pharmaceuticals media release, the company is planning to evaluate the full data outputs.
    • 12 Mar 2018 According to an Anthera Pharmaceuticals media release, based on he data from this trial the company is discontinuing further clinical development of Sollpura including the 20-Week Extension Period of RESULT, the SIMPLICITY study and the EASY study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top